首页 > 市场调查报告书 > 製药

糖尿病

市场调查报告书

商品编码

1649660

糖尿病足溃疡治疗市场规模、份额和成长分析（按治疗、溃疡类型、最终用途和地区）- 产业预测 2025-2032

Diabetic Foot Ulcer Treatment Market Size, Share, and Growth Analysis, By Treatment (Wound Care Dressings, Biologics), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers), By End-use, By Region - Industry Forecast 2025-2032

出版日期: 2025年02月02日 | 出版商:

SkyQuest | 英文 211 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年全球糖尿病足溃疡治疗市场规模价值 46.4 亿美元，预计将从 2024 年的 48.9 亿美元增长到 2032 年的 74.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.4%。

受糖尿病盛行率上升、人口老化和创伤护理技术进步的推动，糖尿病足溃疡治疗市场正在经历显着增长。美国约有 1.3 亿人患有糖尿病或糖尿病前期，对有效治疗方案的需求迅速增长。此外，随着老年人口的增加，糖尿病相关併发症如足部溃疡的发生率也增加。伤口护理的创新，包括先进的敷料、生物活性材料、负压伤口护理和高压氧气疗法，正在彻底改变治疗方法并改善创伤治疗效果。这些人口趋势加上技术进步，引起了患者和医疗保健提供者的兴趣，进一步推动了市场的发展。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

3M（United States）
Smith+Nephew（United Kingdom）
ConvaTec Group Plc（United Kingdom）
Coloplast A/S（Denmark）
Molnlycke Health Care AB（Sweden）
Integra LifeSciences Holdings Corporation（United States）
Cardinal Health, Inc.（United States）
B. Braun Melsungen AG（Germany）
Medtronic plc（Ireland）
Essity Aktiebolag（publ）（Sweden）
MIMEDX Group, Inc.（United States）
Tissue Regenix Group plc（United Kingdom）
Derma Sciences, Inc.（United States）
Medline Industries, LP（United States）
MPM Medical, Inc.（United States）
Hartmann Group（Germany）
DermaRite Industries, LLC（United States）
BioMonde（United Kingdom）
Sanara MedTech Inc.（United States）

结论和建议

简介目录

Product Code: SQMIG35D2236

Global Diabetic Foot Ulcer Treatment Market size was valued at USD 4.64 billion in 2023 and is poised to grow from USD 4.89 billion in 2024 to USD 7.45 billion by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).

The diabetic foot ulcer treatment market is experiencing significant growth, fueled by a rising prevalence of diabetes, an aging population, and advancements in wound care technology. With approximately 130 million individuals in the U.S. affected by diabetes or prediabetes, the demand for effective treatment options is surging. Additionally, as the senior population grows, so does the incidence of diabetes-related complications like foot ulcers. Innovations in wound care, including advanced dressings, bioactive materials, negative pressure wound therapy, and hyperbaric oxygen therapy, are revolutionizing treatment approaches and enhancing wound healing outcomes. This combination of demographic trends and technological advancements is driving increased interest from both patients and healthcare providers, further propelling the market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Foot Ulcer Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetic Foot Ulcer Treatment Market Segments Analysis

Global Diabetic Foot Ulcer Treatment Market is segmented by Treatment, Ulcer Type, End-use and Region. Based on Treatment, the market is segmented into Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Others. Based on Ulcer Type, the market is segmented into Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers. Based on End-use, the market is segmented into Hospitals, Ambulatory Imaging Center and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetic Foot Ulcer Treatment Market

The global market for diabetic foot ulcer treatment is witnessing significant growth, driven by innovations in wound care technology including growth factor therapies, bioengineered skin substitutes, and advanced dressings. These advancements not only improve patient outcomes but also expedite the healing process and reduce infection risks. For instance, antimicrobial dressings play a crucial role in preventing common infections associated with diabetic foot ulcers, while bioengineered skin substitutes serve as effective scaffolds for tissue regeneration, promoting faster recovery. The continuous evolution of these state-of-the-art technologies is revolutionizing patient care globally, enhancing the effectiveness and efficiency of treatments for diabetic foot ulcers.

Restraints in the Global Diabetic Foot Ulcer Treatment Market

A significant challenge facing the global diabetic foot ulcer treatment market is the limited accessibility of healthcare resources and facilities in developing countries. In many low- and middle-income nations, particularly in rural areas, the healthcare system remains underdeveloped, leading to inadequate access to specialized care for diabetic foot ulcers. Patients in these regions often struggle to receive timely diagnoses, appropriate wound management, and advanced treatment options. This lack of access may contribute to poorer health outcomes, increased complications, and prolonged healing times, ultimately hindering the overall progress and effectiveness of diabetic foot ulcer interventions on a global scale.

Market Trends of the Global Diabetic Foot Ulcer Treatment Market

The Global Diabetic Foot Ulcer Treatment market is experiencing significant growth driven by the rising prevalence of diabetes worldwide. As diabetic foot ulcers become increasingly common and pose serious health risks, the market is witnessing a shift towards advanced wound care technologies. Innovative solutions such as growth factors, bioengineered skin substitutes, and negative pressure wound therapy are being prioritized, offering more efficient and effective healing alternatives compared to traditional methods. Companies are investing heavily in research and development to launch cutting-edge products that not only expedite healing but also reduce complications, thereby reshaping the treatment landscape for diabetic foot ulcers.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Diabetic Foot Ulcer Treatment Market Size by Treatment & CAGR (2025-2032)

Market Overview
Wound Care Dressings
- Alginate Dressings
- Hydrofiber Dressings
- Foam Dressings
- Film Dressing
- Hydrocolloid Dressings
- Surgical Dressings
- Hydrogel Dressings
Biologics
- Growth Factors
- Skin Grafts
Therapy Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
Antibiotic Medications
Others

Global Diabetic Foot Ulcer Treatment Market Size by Ulcer Type & CAGR (2025-2032)

Market Overview
Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic Ulcers

Global Diabetic Foot Ulcer Treatment Market Size by End-use & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Imaging Center
Homecare

Global Diabetic Foot Ulcer Treatment Market Size & CAGR (2025-2032)

North America (Treatment, Ulcer Type, End-use)
- US
- Canada
Europe (Treatment, Ulcer Type, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment, Ulcer Type, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment, Ulcer Type, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment, Ulcer Type, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

3M (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith+Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConvaTec Group Plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essity Aktiebolag (publ) (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MIMEDX Group, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissue Regenix Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Derma Sciences, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, LP (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MPM Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hartmann Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DermaRite Industries, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMonde (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanara MedTech Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments